Back to Journals » OncoTargets and Therapy » Volume 11

Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials

Total article views   HTML views PDF downloads Totals
12,170 Dovepress* 9,967+ 861 10,828
PubMed Central* 2,203 500 2,703
Totals 12,170 1,361 13,531
*Since 21 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar